Girinimbine Inhibits the Proliferation of Human Ovarian Cancer Cells In Vitro via the Phosphatidylinositol-3-Kinase (PI3K)/Akt and the Mammalian Target of Rapamycin (mTOR) and Wnt/β-Catenin Signaling Pathways

Qiu Xin, An Muer

Open source

DOI
10.12659/msm.910137
Published
2018-08-07
Container
Medical Science Monitor
Publisher
International Scientific Information, Inc.
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.12659/msm.910137,
  title = {Girinimbine Inhibits the Proliferation of Human Ovarian Cancer Cells In Vitro via the Phosphatidylinositol-3-Kinase (PI3K)/Akt and the Mammalian Target of Rapamycin (mTOR) and Wnt/β-Catenin Signaling Pathways},
  author = {Qiu Xin and An Muer},
  year = {2018},
  journal = {Medical Science Monitor},
  doi = {10.12659/msm.910137},
  url = {https://doi.org/10.12659/msm.910137}
}

RIS

TY  - JOUR
TI  - Girinimbine Inhibits the Proliferation of Human Ovarian Cancer Cells In Vitro via the Phosphatidylinositol-3-Kinase (PI3K)/Akt and the Mammalian Target of Rapamycin (mTOR) and Wnt/β-Catenin Signaling Pathways
AU  - Qiu Xin
AU  - An Muer
PY  - 2018
JO  - Medical Science Monitor
DO  - 10.12659/msm.910137
UR  - https://doi.org/10.12659/msm.910137
ER  - 

APA

Xin, Q., & Muer, A. (2018). Girinimbine Inhibits the Proliferation of Human Ovarian Cancer Cells In Vitro via the Phosphatidylinositol-3-Kinase (PI3K)/Akt and the Mammalian Target of Rapamycin (mTOR) and Wnt/β-Catenin Signaling Pathways. Medical Science Monitor. https://doi.org/10.12659/msm.910137

Source records